These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11334580)

  • 1. [Effect on plasma fibrinogen of hypercholesterolaemia treatment with pravastatin].
    Murciano Revert J; Martínez-Lahuerta JJ; Aleixandre Porcar L; Debón Belda M
    Aten Primaria; 2001 Apr; 27(6):417-21. PubMed ID: 11334580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.
    Bak AA; Huizer J; Leijten PA; Rila H; Grobbee DE
    J Intern Med; 1998 Nov; 244(5):371-8. PubMed ID: 9845852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
    Contacos C; Barter PJ; Vrga L; Sullivan DR
    Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins improve visual field alterations related to hypercholesterolemia.
    Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
    Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.
    Pfeffer MA; Sacks FM; Moyé LA; East C; Goldman S; Nash DT; Rouleau JR; Rouleau JL; Sussex BA; Theroux P; Vanden Belt RJ; Braunwald E
    J Am Coll Cardiol; 1999 Jan; 33(1):125-30. PubMed ID: 9935018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE; Lapsley D; Gaziano JM
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
    Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
    J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.
    Calza L; Manfredi R; Colangeli V; Pocaterra D; Pavoni M; Chiodo F
    Curr HIV Res; 2008 Nov; 6(6):572-8. PubMed ID: 18991624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.
    McTavish D; Sorkin EM
    Drugs; 1991 Jul; 42(1):65-89. PubMed ID: 1718686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.
    Zanchetti A; Crepaldi G; Bond MG; Gallus GV; Veglia F; Ventura A; Mancia G; Baggio G; Sampieri L; Rubba P; Collatina S; Serrotti E
    J Hypertens; 2001 Jan; 19(1):79-88. PubMed ID: 11204308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
    Lintott CJ; Scott RS; Sutherland WH; Bremer J
    Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin.
    Dangas G; Smith DA; Badimon JJ; Unger AH; Shao JH; Meraj P; Cohen AM; Levine D; Fallon JT; Ambrose JA
    Am J Cardiol; 1999 Sep; 84(6):639-43. PubMed ID: 10498131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The seasonal variation in the plasma fibrinogen concentrations in patients with essential arterial hypertension].
    Murciano Revert J; Martínez-Lahuerta JJ; Porcar LA
    Aten Primaria; 1998 Sep; 22(5):298-301. PubMed ID: 9835136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.